Increasing complexity and the globalization of pharma business models will force organizations to adopt a new unified approach for multi-country sales planning. Sales operations organizations within pharma must prepare to standardize across countries or risk losing business agility and face higher costs to support heavily localized business processes and nonstrategic technologies. This paper will explore the best practices and superior capabilities that can help reduce costs globally, even in the most cost-sensitive markets.